A multifactorial analysis of first-author retention in ASCO accepted works.
Abstract
9045 Background: Ensuring clinician oncologists remain engaged with research is an important step in maintaining optimal patient care in a rapidly changing field, and can be especially difficult for clinicians of marginalized groups. To identify trends in research engagement among oncologists, we performed a retrospective analysis on first-author retention in ASCO accepted works from 2019-2024, focusing on year presented, presentation type, and gender. Methods: Data from publicly available ASCO works from 2019 to 2024 were obtained from ASCO online materials, including first author (or speaker/chair) and presentation type (limited to education session, oral abstract, poster discussion session, poster session, and online-only ASCO meeting publication). Gender was identified by name using Namsor, a public web-tool. Names that could not be predicted by the web-tool were identified manually by physical presentation on institutional websites, if possible. An original script was created to identify first-author retention year-to-year, outputting the proportion of first authors found in both years and appropriate statistical tests. This analysis focused on comparing one-year retention (e.g. 2019-2020, 2020-2021, etc.). Results: We found that the period with the highest one-year first-author retention of all works was during 2022 to 2023, with 22% retention (985 of 4445 first-authors). First-author retention remained 20-22% for all other periods analyzed, except during 2023-2024 where retention decreased to 15% (806/5568; Two-proportion test comparing 2022-2023 and 2023-2024: p < 0.001). Focusing on specific presentation types, education sessions were found to have the lowest one-year retention, averaging 5.1%, as compared with poster sessions, which had the highest average one-year retention of 15.3% (Two-proportion test: p < 0.001). Looking at gender, we found that education sessions were the least male-prevalent, with an average of 49.6% retained speakers being male across all years. For oral abstracts, poster discussion sessions, and online-only publications, 53-54% of retained first-authors were male. Notably, first-author retention in poster sessions was much more male-prevalent, with an average of 62.7% of first-authors being male (Two-proportion test comparing male proportion in education and poster sessions: p = 0.002). Lastly, we found that five-year first-author retention of all works from 2019 to 2024 was significantly male-dominated, with 61% of those retained being male (267/437; one-proportion test p < 0.001). Conclusions: Trends of retention at a major oncology conference were identified, including recent decreases in retention, which could be due to a relative increase in first-time authors. The male prevalence in poster sessions and decrease in first-author retention of women over longer periods of time reveal specific areas to create more equitable opportunities for women in research.
Article Details
Journal Info
Journal of Clinical Oncology
Lippincott Williams & Wilkins
Authors (4)
Taha Huda
1HCA Florida Bayonet Point Hospital, Internal Medicine Program, Hudson, United States
Bret R. Miller
Department of Medicine, Baylor College of Medicine, Houston, TX
Sara Ahmed Khan
HCA Healthcare/USF Morsani College of Medicine GME: Bayonet Point Hospital, Hudson, FL
Alexander F. Gutierrez
HCA Healthcare/USF Morsani College of Medicine GME: Bayonet Point Hospital, Hudson, FL